Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AbbVie : to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference

11/25/2020 | 09:55am EST

NORTH CHICAGO - AbbVie (NYSE: ABBV) will participate in the Evercore ISI Virtual HealthCONx Conference on Wednesday, December 2 at 1:40 p.m. CT and the Piper Sandler Virtual Healthcare Conference on Thursday, December 3 at 10 a.m. CT.

Michael Severino, M.D., vice chairman and president, and Robert A. Michael, executive vice president and chief financial officer, will present at both conferences.

A live audio webcast of each presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the sessions will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Contact:

Adelle Infante

Tel: +1 (847) 938-8745

Email: adelle.infante@abbvie.com

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about ABBVIE INC.
01/18ABBVIE : Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neur..
AQ
01/15ABBVIE : Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neur..
PR
01/14ABBVIE INC. : Ex-dividend day for
FA
01/13SECTOR UPDATE : Health Care Stocks Rise in Cautious Wednesday Trade
MT
01/13SECTOR UPDATE : Health Care Stocks Maintaining Moderate Advance
MT
01/13GENMAB A/S : to Receive $40 Million Milestone Payment From AbbVie
MT
01/13HARPOON THERAPEUTICS : FDA Grants Orphan Drug Status to Harpoon Therapeutics, Ab..
MT
01/12ABBVIE : J.P. Morgan Healthcare Conference Presentation 985.1 KB
PU
01/12ABBVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
01/12ABBVIE : Unit Allergan Enters Into Option to Buy Cypris Medical
MT
More news
Financials (USD)
Sales 2020 45 626 M - -
Net income 2020 12 344 M - -
Net Debt 2020 75 457 M - -
P/E ratio 2020 27,2x
Yield 2020 4,30%
Capitalization 196 B 196 B -
EV / Sales 2020 5,94x
EV / Sales 2021 4,80x
Nbr of Employees 47 000
Free-Float 98,5%
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 115,91 $
Last Close Price 110,86 $
Spread / Highest target 21,8%
Spread / Average Target 4,55%
Spread / Lowest Target -12,5%
EPS Revisions
Managers and Directors
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC.3.46%195 720
JOHNSON & JOHNSON3.92%430 552
ROCHE HOLDING AG3.06%308 615
NOVARTIS AG2.73%220 726
MERCK & CO., INC.-1.00%204 882
PFIZER INC.-0.71%203 159